MX9703461A - Nuevas composiciones basadas en una mezcla sinergistica de al menos un ligando vdr y un retinoide. - Google Patents
Nuevas composiciones basadas en una mezcla sinergistica de al menos un ligando vdr y un retinoide.Info
- Publication number
- MX9703461A MX9703461A MX9703461A MX9703461A MX9703461A MX 9703461 A MX9703461 A MX 9703461A MX 9703461 A MX9703461 A MX 9703461A MX 9703461 A MX9703461 A MX 9703461A MX 9703461 A MX9703461 A MX 9703461A
- Authority
- MX
- Mexico
- Prior art keywords
- ligands
- retinoids
- vrd
- compositions based
- novel compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
La invencion describe una nueva combinacion de uno o más ligandos con actividad selectiva del receptor VDR y uno o más retinoides selectivos para receptores RAR-gamma con respecto a los receptores RAR-alfa, así como al uso de ésta en aplicacion cosmética y cuidados de la piel para el tratamiento de trastornos relacionados con la hiperproliferacion de células, en particular células de la piel, tal como la psoriasis.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9510854A FR2738745B1 (fr) | 1995-09-15 | 1995-09-15 | Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide, et leurs utilisations |
FR95/10854 | 1995-09-15 | ||
PCT/FR1996/001386 WO1997009987A1 (fr) | 1995-09-15 | 1996-09-10 | Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9703461A true MX9703461A (es) | 1997-07-31 |
MXPA97003461A MXPA97003461A (es) | 1997-12-01 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
BR9606648A (pt) | 1997-09-16 |
JP2898100B2 (ja) | 1999-05-31 |
BR9606648B1 (pt) | 2009-01-13 |
US6759396B1 (en) | 2004-07-06 |
ATE218349T1 (de) | 2002-06-15 |
PT788361E (pt) | 2002-11-29 |
JPH10503533A (ja) | 1998-03-31 |
AU687687B2 (en) | 1998-02-26 |
WO1997009987A1 (fr) | 1997-03-20 |
EP0788361B1 (fr) | 2002-06-05 |
AU6991296A (en) | 1997-04-01 |
CA2204437C (fr) | 2003-06-10 |
FR2738745A1 (fr) | 1997-03-21 |
CA2204437A1 (fr) | 1997-03-20 |
DK0788361T3 (da) | 2002-07-15 |
FR2738745B1 (fr) | 1997-10-24 |
EP0788361A1 (fr) | 1997-08-13 |
DE69621580D1 (de) | 2002-07-11 |
DE69621580T2 (de) | 2003-03-13 |
ES2181908T3 (es) | 2003-03-01 |
NZ318430A (en) | 2000-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU687687B2 (en) | Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids | |
NZ231832A (en) | Pharmaceutical or cosmetic composition for topical application containing microspheres of diameter 3-10mum | |
ZA932403B (en) | Skin care method and composition. | |
HU9401105D0 (en) | Low ph aqueous cosmetic gel containing non-ionic polyacrylamide derivatives | |
EP0660698A1 (fr) | Composition cosmetique ou dermatologique contenant au moins une saponine de type ginsenoside, et ses applications, notamment pour le soin des cheveux. | |
TW280773B (es) | ||
TR199801501T1 (xx) | Yeni form�lasyon. | |
ATE137665T1 (de) | Kosmetisches mittel | |
CA2135575A1 (fr) | Composition cosmetique contenant en tant qu'agent reducteur un n-mercapto-alkyl alcanediamide ou l'un de ses sels cosmetiquement acceptable | |
DE69407419D1 (de) | 2' oder 3' -deoxy- und 2' -dideoxy-beta-l-pentafuranonukleoside, verfahren zur herstellung und anwendung in der therapie, insbesondere als antivirale wirkstoffe | |
SG81882A1 (en) | Retinoid composition | |
DE69831404D1 (de) | Verwendung von mindestens einem irvingia gabonensis-extrakt in kosmetischen und/oder pharmazeutischen produkten | |
CA2179778A1 (en) | Deuterised active agents in transdermal application | |
WO1998038968A3 (de) | Kosmetisches körperpflegepräparat das honig enthält und verfahren zu seiner herstellung | |
ITPN920030A0 (it) | Composizione per uso topico avente attivita' di stimolo per la ricrescita, di rinvigorimento, di prevenzione dell'ingrigimento e di ripigmentazione naturale dei capelli | |
MY131368A (en) | Synthetic detergent total body care product | |
ES2121463T3 (es) | Uso de procisteina como agente blanqueante de la piel. | |
DE59803222D1 (de) | Kosmetische mittel | |
KR960700729A (ko) | 26,26,26,27,27,27-헥사플루오로-1 알파, 25-디히드록시콜레칼시페롤의 칼슘 대사 장애의 치료 용도(Use of 26,26,26,27,27,27-Hexafluoro-1alpha, 25-Dihydroxycholecalciferol for the treatment of Calcium Metabolism Disorders) | |
RU94008830A (ru) | Основа для косметических средств |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |